141 related articles for article (PubMed ID: 36156374)
1. Generation and characterization of patient-derived xenografts from patients with osteosarcoma.
Chen F; Zhang Z; Shen R; Chen M; Li G; Zhu X
Tissue Cell; 2022 Dec; 79():101911. PubMed ID: 36156374
[TBL] [Abstract][Full Text] [Related]
2. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
Nanni P; Landuzzi L; Manara MC; Righi A; Nicoletti G; Cristalli C; Pasello M; Parra A; Carrabotta M; Ferracin M; Palladini A; Ianzano ML; Giusti V; Ruzzi F; Magnani M; Donati DM; Picci P; Lollini PL; Scotlandi K
Sci Rep; 2019 Aug; 9(1):12174. PubMed ID: 31434953
[TBL] [Abstract][Full Text] [Related]
3. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma.
Landuzzi L; Manara MC; Lollini PL; Scotlandi K
Cells; 2021 Feb; 10(2):. PubMed ID: 33671173
[TBL] [Abstract][Full Text] [Related]
4. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
Clin Cancer Res; 2024 Feb; 30(4):849-864. PubMed ID: 37703185
[TBL] [Abstract][Full Text] [Related]
5. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
7. Establishment of 6 pediatric rhabdomyosarcoma patient's derived xenograft models closely recapitulating patients' tumor characteristics.
Gasparini P; Casanova M; Centonze G; Borzi C; Bergamaschi L; Collini P; Testi A; Chiaravalli S; Massimino M; Sozzi G; Ferrari A; Moro M
Tumori; 2023 Jun; 109(3):314-323. PubMed ID: 36114629
[TBL] [Abstract][Full Text] [Related]
8. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.
Castillo-Ecija H; Pascual-Pasto G; Perez-Jaume S; Resa-Pares C; Vila-Ubach M; Monterrubio C; Jimenez-Cabaco A; Baulenas-Farres M; Muñoz-Aznar O; Salvador N; Cuadrado-Vilanova M; Olaciregui NG; Balaguer-Lluna L; Burgueño V; Vicario FJ; Manzanares A; Castañeda A; Santa-Maria V; Cruz O; Celis V; Morales La Madrid A; Garraus M; Gorostegui M; Vancells M; Carrasco R; Krauel L; Torner F; Suñol M; Lavarino C; Mora J; Carcaboso AM
J Pathol Clin Res; 2021 Jul; 7(4):338-349. PubMed ID: 33837665
[TBL] [Abstract][Full Text] [Related]
10. Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues.
Sun X; Chang J; Zhou C; Zhao P; Guo S; Tong J; Wang Y; Yang Y
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38587398
[TBL] [Abstract][Full Text] [Related]
11. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
[TBL] [Abstract][Full Text] [Related]
12. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
13. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
[TBL] [Abstract][Full Text] [Related]
15. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
Pan CX; Zhang H; Tepper CG; Lin TY; Davis RR; Keck J; Ghosh PM; Gill P; Airhart S; Bult C; Gandara DR; Liu E; de Vere White RW
PLoS One; 2015; 10(8):e0134346. PubMed ID: 26270481
[TBL] [Abstract][Full Text] [Related]
16. Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.
Drapkin BJ; George J; Christensen CL; Mino-Kenudson M; Dries R; Sundaresan T; Phat S; Myers DT; Zhong J; Igo P; Hazar-Rethinam MH; Licausi JA; Gomez-Caraballo M; Kem M; Jani KN; Azimi R; Abedpour N; Menon R; Lakis S; Heist RS; Büttner R; Haas S; Sequist LV; Shaw AT; Wong KK; Hata AN; Toner M; Maheswaran S; Haber DA; Peifer M; Dyson N; Thomas RK; Farago AF
Cancer Discov; 2018 May; 8(5):600-615. PubMed ID: 29483136
[TBL] [Abstract][Full Text] [Related]
17. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.
Sengal AT; Pollock PM
Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799
[TBL] [Abstract][Full Text] [Related]
18. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Patient-Derived Xenograft Modeling and Prognosis in Osteosarcoma.
Sun M; Wang Z; Sun W; Chen M; Ma X; Shen J; Fu Z; Zuo D; Wang G; Wang H; Wang C; Yin F; Wang Z; Zhang C; Hua Y; Cai Z
Orthop Surg; 2022 Jun; 14(6):1161-1166. PubMed ID: 35538733
[TBL] [Abstract][Full Text] [Related]
20. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
